TP53 and B-cell chronic lymphocytic leukemia: A causative relationship between p53 loss and a decrease in miR-15/16 in the development of CLL was demonstrated in a mouse model, suggesting that the p53-miR15/miR-16-MCL1 axis may contribute to aggressiveness and drug resistance in CLL cells (9).